Author Question: A researcher is investigating some of the behavioral properties of a new drug called GR1944 (a ... (Read 34 times)

jenna1

  • Hero Member
  • *****
  • Posts: 568
A researcher is investigating some of the behavioral properties of a new drug called GR1944 (a hypothetical drug).
 
  She trains two groups of rats on tasks in which bar pressing is occasionally reinforced with food. For GROUP DRLR rats the longer the interval between bar presses the greater the likelihood that a bar press will be rewarded, so GROUP DRLR rats generally press the bar fairly infrequently. For GROUP DRHR rats the shorter the interval between bar presses the greater the likelihood that a bar press will be rewarded, so GROUP DRHR rats press the bar fairly rapidly. After the two groups are trained over several daily sessions to the point that their responding is at stable levels, the researcher splits the two groups into two subgroups. For five successive daily test sessions, she injects GROUP DRLR-1 and GROUP DRHR-1 rats with 100 mg of GR1944 30 minutes prior to each session, and for five successive daily test sessions, she injects GROUP DRLR-2 and GROUP DRHR-2 rats with saline 30 minutes prior to each session. The researcher measures the rate of bar pressing for each group over the five test sessions.
  The researcher notes that after the first injection of GR1944, the GROUP DRLR-1 and GROUP DRHR-1 rats respond much more frequently than their counterpart controls (i.e., GROUPs DRLR-2 and DRHR-2). However, by the fifth test session, the GROUP DRLR-1 rats are responding at about the same level as the GROUP DRLR-2 rats, i.e., it appears that tolerance to GR1944 has occurred. On the other hand, by the fifth test session, the GROUP DRHR-1 rats are still responding much faster than the GROUP DRHR-2 rats, i.e., tolerance to GR1944 does not appear to have occurred.
  1. Are these observations more compatible with a pharmacodynamic or a context-specific mechanism for tolerance development? Explain your reasoning.
 
  What will be an ideal response?

Question 2

Which of the following is not included in the category of monoamine neurotransmitters?
 
  a. serotonin
  b. norepinephrine
  c. dopamine
  d. endorphins



debra928

  • Sr. Member
  • ****
  • Posts: 342
Answer to Question 1

Since both groups DRLR-1 and DRHR-1 were given the same amount of GR1944 over the same time intervals and only one group exhibited tolerance, a pharmacodynamic mechanism can be ruled out, leaving a context-specific mechanism resulting from the fact that the task requirements for the two groups of rats were very different. Specifically, group DRLR-1 rats would have lost reinforcers upon exposure to GR1944 because it resulted in them responding more frequently, whereas group DRHR-1 rats would likely increase their reinforcement rate with the drug because the responded even more rapidly than without the drug. Thus, one would predict that group DRLR-1 rats would learn some compensatory instrumental behaviors that resulted in them decreasing their rate of responding to reestablish their original rate of reinforcement, i.e., show tolerance. Since there would be nothing for group DRHR-1 rats to compensate for, they would show no tolerance.

Answer to Question 2

d



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

After 5 years of being diagnosed with rheumatoid arthritis, one every three patients will no longer be able to work.

Did you know?

The first oral chemotherapy drug for colon cancer was approved by FDA in 2001.

Did you know?

Elderly adults are at greatest risk of stroke and myocardial infarction and have the most to gain from prophylaxis. Patients ages 60 to 80 years with blood pressures above 160/90 mm Hg should benefit from antihypertensive treatment.

Did you know?

There are actually 60 minerals, 16 vitamins, 12 essential amino acids, and three essential fatty acids that your body needs every day.

Did you know?

In Eastern Europe and Russia, interferon is administered intranasally in varied doses for the common cold and influenza. It is claimed that this treatment can lower the risk of infection by as much as 60–70%.

For a complete list of videos, visit our video library